All stock lists
Regional Health Properties, Inc (OTC:RHEP)
US · Delayed Price · Currency is USD
Healthcare · Medical - Care Facilities
1.02+0.02 (+2.00%)
Insider Score
––Not scored
RHEP Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Fair
From RHEP’s reported statements · Q2 2026 (trailing 12 months)
Profitability12 / 20
Profitable, but on a thin margin.
- Revenue
- $81.5M
- Net income
- $4.1M
- Net margin
- 5.0%
Leverage0 / 20
Heavily indebted for what it earns.
- Total debt
- $41.8M
- Cash
- $1.7M
- Net debt / EBITDA
- 4.18x
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $17.7M
- Current liabilities
- $5.8M
- Current ratio
- 3.03
Cash generation9 / 20
Roughly cash-neutral.
- Operating cash flow
- -$2.6M
- Free cash flow
- -$3.9M
- FCF margin
- -4.8%
Dilution & runway2 / 20
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 0.0M
- Share growth (1y)
- -99.8%
- Cash runway
- 8 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
RHEP Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 24.44 M | 21.16 M | 20.77 M | 15.14 M | 10.06 M | 7.19 M |
| Revenue Growth (YoY) | 143.03 % | 194.33 % | 267.05 % | 258.30 % | 132.53 % | 74.22 % |
| Cost of Revenue | 18.50 M | 15.88 M | 14.21 M | 12.40 M | 7.33 M | 4.61 M |
| Gross Profit | 5.94 M | 5.28 M | 6.57 M | 2.74 M | 2.72 M | 2.58 M |
| SG&A Expense | 6.70 M | 6.52 M | -8.36 M | 3.71 M | 2.43 M | 2.23 M |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 6.15 M | 5.98 M | 5.43 M | 3.33 M | 3.23 M | 2.90 M |
| Operating Income | -216.00 K | -702.00 K | 937.00 K | -594.00 K | -508.00 K | -15.00 K |
| Pretax Income | -791.00 K | -1.22 M | 2.70 M | 3.38 M | -1.45 M | -1.26 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -791.00 K | -1.22 M | 2.70 M | 3.38 M | -1.45 M | -1.26 M |
| EPS (Basic) | -0.20 | -0.29 | 1.54 | 1.17 | -0.68 | -0.94 |
| EPS (Diluted) | -0.20 | -0.29 | 1.54 | 1.17 | -0.68 | -0.94 |
| Shares Outstanding | 3.93 K | 3.94 K | 2.81 K | 3.13 M | 2.14 M | 1.99 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.